Searched for
INDIA FORMULATION STORY
India's next telecom battle could be fought on highways, with connected carsIndia's telecom wars have traditionally revolved around spectrum, towers and tariffs. But a new consultation paper by TRAI on Vehicle-to-Ev...- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- Hold senior bureaucrats accountable for lapses: Allahabad High Court to Uttar Pradesh Chief Minister Yogi AdityanathThe Allahabad High Court has called for accountability from senior bureaucrats from Uttar Pradesh. Chief Minister Yogi Adityanath has been ...
- Assam seeks Centre's backing for energy, health pushAssam Chief Minister Himanta Biswa Sarma met with Union Ministers Manohar Lal Khattar, Mansukh Mandaviya, and Jagat Prakash Nadda to discus...
- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- ‘Balika Vadhu’ fame Neha Marda started a business with Rs 10, now earns crores every month with 2 lakh customersActress Neha Marda transitioned from television to entrepreneurship, launching an alum-based underarm roll-on brand. Inspired by personal p...
- Yogi Adityanath's caste recalibration: BJP expands cabinet to reclaim UP’s social coalition before 2027 pollsYogi Adityanath Cabinet Expansion 2026: Uttar Pradesh Chief Minister Yogi Adityanath's cabinet expansion is a clear political signal. The B...
- States' average per capita income could hit upper threshold by 2047, if growth sustains: RBI DGBy the year 2046-47, it's anticipated that India's average per capita income could soar into high-income territory, contingent upon the con...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- How a Vadodara startup built a family idea into a business without chasing the spotlightBriyo, a Vadodara startup, achieved growth without early investor funding or aggressive marketing. The company focused on product quality a...
- Select midcap pharma, media & IT stocks poised to do well next 3-5 years: Varun Goel“From a margin perspective, things are getting better and revenue growth should start accelerating from the third quarter onwards. Therefor...
- Bulk drug exports to grow 12-14% till 2018-19: AssochamThe study also said that the domestic formulations market is likely to cross USD 20 billion mark by 2018-19 from a level of about USD 11 bi...
- Treat investors as stakeholders in India's growth: DeloitteThe Deloitte study said the approach will take the defining partnership between India and the US to the next level of growth and developmen...
Load More
